JORDAN DEWOODY: Open Payments
NPI 1851963888 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 29 payments from 11 companies in 2025. Trend: 2023 $533 · 2024 $2,610 · 2025 $682
Food & beverage: $682
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $157 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $88 |
| Janssen Biotech, Inc. | 4 | $72 |
| Ferring Pharmaceuticals Inc. | 3 | $71 |
| Sumitomo Pharma America, Inc. | 3 | $64 |
| Endo USA, Inc. | 3 | $58 |
| Teleflex LLC | 2 | $51 |
| ABBVIE INC. | 3 | $48 |
| UROGEN PHARMA, INC. | 2 | $36 |
| COLOPLAST CORP | 1 | $21 |
Products named: Axonics, JOURNAVX, ERLEADA, ADSTILADRIN, ORGOVYX, XIAFLEX, LUPRON DEPOT, UROLIFT.
Industry payments across MO — which companies pay providers there.
